PT  - JOURNAL ARTICLE
AU  - Varun Sharma
AU  - Indu Sharma
AU  - Love Gupta
AU  - Garima Rastogi
AU  - Anuka Sharma
TI  - Polygenic Risk Score Comparative Analyses Reveals Risk Disparity of Genetic Predisposition to Chronic Kidney Disease- A Multi Ancestry Approach
AID  - 10.1101/2022.07.05.22277245
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.07.05.22277245
4099  - http://medrxiv.org/content/early/2022/07/06/2022.07.05.22277245.short
4100  - http://medrxiv.org/content/early/2022/07/06/2022.07.05.22277245.full
AB  - Polygenic Risk Score (PRS) models are used extensively to find the population/individual risk towards disease. These predictive scores are of great help as risk scores if predicted earlier the life of individual can be saved from the chronic/ complex diseases. In this empirical assessments study, the polygenic risk score was calculated in three different ancestries (SAS, EAS and African Americans) based on more than three hundred markers. The risk score we observed indicated that average population risk scores are varied but on cumulating the ancestries the average risk score increased ∼1.3 times than individual population average risk. The parameter which varies greatly while calculating the PRS is the ancestry; it should be prerequisite that individuals of same ancestry should be taken as a one population groups while calculating the scores.Competing Interest StatementThe authors have declared no competing interest.Funding Statementthere was no funding for the present studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesthe data used in the manuscript are submitted as supplementary data along with the MS.